X4 Pharmaceuticals, Inc.

Filed a patent for "methods for treating primary immunodeficiency" on Thu, June 6, 2024

Filed a patent for "cxcr4 inhibitors for treatment of neurological diseases" on Wed, October 26, 2022

Filed a patent for "mdr e. coli immunogen" on Thu, September 7, 2023

Filed a patent for "compositions of cxcr4 inhibitors and methods of preparation and use" on Thu, February 22, 2024

Filed a patent for "cxcr4 inhibitors and uses thereof" on Thu, May 9, 2024

Filed a patent for "combination treatments for waldenstrom's macroglobulinemia" on Thu, November 2, 2023

Filed a patent for "methods for treating neutropenia" on Thu, January 19, 2023